SAXS Analizi ile HERC5 HECT Alanının Trimerik Oluşumuna İlişkin Yapısal Bilgiler

Year 2025, Volume: 53 Issue: 4, 91 - 100, 01.10.2025

Cansu Deniz Tozkoparan Ceylan Çağdaş Dağ

https://doi.org/10.15671/hjbc.1675606

https://izlik.org/JA96ZE89LG

Abstract

HERC5, antiviral yanıtları düzenleyen önemli bir post-translasyonel modifikasyon olan ISGylation yolağında yer alan interferon kaynaklı bir E3 ubikitin ligazdır. HERC5'in HECT alanı, substrat tanıma ve ubikitin transferinde önemli bir rol oynar. HERC protein ailesi yapısal olarak C-terminal HECT (Homologous to the E6-AP Carboxyl Terminus) alanı ve N-terminal RCC1 benzeri (The Regulator of Chromosome Condensation 1) alanları içermesiyle karakterize edilir. Buna rağmen, HERC5'in HECT alanına özgü oligomerizasyon kapasitesi tam olarak açıklığa kavuşturulmamıştır. Burada, HERC5 HECT alanının çözeltideki oligomerik durumunu, afinite ve boyut dışlama kromatografisi ile saflaştırılmasının ardından 2.0 mg/ml ve 10°C'de SAXS( Küçük Saçınımlı X-Ray) kullanarak araştırıyoruz. SAXS veri analizi, Guinier ve Kratky analizleri, mesafe dağılım fonksiyonları ve ab initio modelleme ile desteklenen trimerik bir birleşim ortaya koymuştur. Bu bulgular, trimerizasyonun HERC5 işlevinde düzenleyici bir rol oynayabileceğini ve HECT tipi E3 ligaz mekanizmalarının daha geniş bir şekilde anlaşılmasına katkıda bulunabileceğini göstermektedir.

Keywords

HERC5 , HECT domain , SAXS , ISGylasyon , ubiquitin ligaz , protein yapısı

Project Number

120Z594

Structural Insights into the Trimeric Assembly of the HERC5 HECT Domain through SAXS Analysis

https://izlik.org/JA96ZE89LG

Abstract

HERC5 is an interferon-induced E3 ubiquitin ligase involved in ISGylation, a crucial post-translational modification regulating antiviral responses. The HECT domain of HERC5 plays a key role in substrate recognition and ubiquitin transfer. The HERC protein family is structurally characterized by containing the C-terminal HECT (Homologous to the E6-AP Carboxyl Terminus) domain and N-terminal RCC1-like ( The Regulator of Chromosome Condensation 1) domains. In spite of this, the HECT domain-specific oligomerization capacity of HERC5 is not fully clarified. Here, we investigate the oligomeric state of the HERC5 HECT domain in solution, using affinity and size-exclusion chromatography, followed by SAXS measurements at 2.0 mg/ml and 10°C. SAXS data analysis revealed a trimeric assembly, supported by Guinier and Kratky analyses, distance distribution functions, and ab initio modeling. These findings suggest that trimerization may play a regulatory role in HERC5 function, contributing to a broader understanding of HECT-type E3 ligase mechanisms.

Keywords

HERC5 , HECT domain , SAXS , ISGylation , ubiquitin ligase , protein structure

Project Number

120Z594

Thanks

The authors acknowledge the use of the services and facilities of n2STAR-Koç University Nanofabrication and Nanocharacterization Center for Scientific and Technological Advanced Research.

References

• Y.C. Perng, D.J. Lenschow, ISG15 in antiviral immunity and beyond, Nat. Rev. Microbiol., 16 (2018) 423–439.
• T. Abe, N. Minami, R.G. Bawono, C. Matsui, L. Deng, T. Fukuhara, Y. Matsuura, I. Shoji, ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A, J. Virol., 94 (2020) e00532‑20.
• D. Rotin, S. Kumar, Physiological functions of the HECT family of ubiquitin ligases, Nat. Rev. Mol. Cell Biol., 10 (2009) 398–409.
• J.J. Wong, Y.F. Pung, N.S. Sze, K.C. Chin, HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets, Proc. Natl. Acad. Sci. U.S.A., 103 (2006) 10735–10740.
• F. Bernassola, M. Karin, A. Ciechanover, G. Melino, The HECT family of E3 ubiquitin ligases: multiple players in cancer development, Cancer Cell, 14 (2008) 10–21.
• J. Sluimer, B. Distel, Regulating the human HECT E3 ligases, Cell Mol. Life Sci., 75 (2018) 3121–3141.
• T. Takeuchi, S. Inoue, H. Yokosawa, Identification and HERC5-mediated ISGylation of novel target proteins, Biochem. Biophys. Res. Commun., 348 (2006) 473–477.
• M.W. Woods, J.N. Kelly, C.J. Hattlmann, J.G. Tong, L.S. Xu, M.D. Coleman, G.R. Quest, J.R. Smiley, S.D. Barr, Human HERC5 restricts an early stage of HIV‑1 assembly by a mechanism correlating with the ISGylation of Gag, Retrovirology, 8 (2011) 95.
• C.E. Blanchet, D.I. Svergun, Small-angle X-ray scattering on biological macromolecules and nanocomposites in solution, Annu. Rev. Phys. Chem., 64 (2013) 37–54.
• Ç. Dağ, C.D. Tozkoparan Ceylan, C.S. Cansız, Inconsistent Protein Stability Despite Pre-HECT Domain Helix: Unveiling Variability in HECT Ligases, Protein Pept. Lett., (2025) advance online publication.
• O. Göcenler, C.M. Yenici, K. Kahraman, C. Büyükdağ, et al., Biomolecular solution X-ray scattering at n2STAR beamline, Muğla J. Sci. Technol., 8 (2022) 60–69.
• M.K. Jagdev, J. Dandapat, D. Vasudevan, Recombinant expression, purification and SAXS analysis of Arabidopsis thaliana ClpC1, Int. J. Biol. Macromol., 167 (2021) 1273–1280.
• V. Receveur-Brechot, D. Durand, How random are intrinsically disordered proteins? A small angle scattering perspective, Curr. Protein Pept. Sci., 13 (2012) 55–75.
• C.D. Putnam, M. Hammel, G.L. Hura, J.A. Tainer, X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution, Q. Rev. Biophys., 40 (2007) 191–285.
• D.A. Jacques, J. Trewhella, Small-angle scattering for structural biology—expanding the frontier while avoiding the pitfalls, Protein Sci., 19 (2010) 642–657.
• S. Skou, R.E. Gillilan, N. Ando, Synchrotron-based small-angle X-ray scattering of proteins in solution, Nat. Protoc., 9 (2014) 1727–1739.
• D.I. Svergun, M.H.J. Koch, Small-angle scattering studies of biological macromolecules in solution, Rep. Prog. Phys., 66 (2003) 1735–1782.
• M.A. Verdecia, C.A. Joazeiro, N.J. Wells, J.L. Ferrer, M.E. Bowman, T. Hunter, J.P. Noel, Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase, Mol. Cell, 11 (2003) 249–259.
• A.A. Ogunjimi, D.J. Briant, N. Pece-Barbara, C. Le Roy, G.M. Di Guglielmo, P. Kavsak, R.K. Rasmussen, B.T. Seet, F. Sicheri, J.L. Wrana, Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain, Mol. Cell, 19 (2005) 297–308.
• R.K. Pandya, J.R. Partridge, K.R. Love, T.U. Schwartz, H.L. Ploegh, A structural element within the HUWE1 HECT domain modulates self-ubiquitination and substrate ubiquitination activities, J. Biol. Chem., 285 (2010) 5664–5673.
• E. Maspero, S. Mari, E. Valentini, A. Musacchio, A. Fish, S. Pasqualato, S. Polo, Structure of the HECT: ubiquitin complex and its role in ubiquitin chain elongation, EMBO Rep., 12 (2011) 342–349.
• L. Huang, E. Kinnucan, G. Wang, S. Beaudenon, P.M. Howley, J.M. Huibregtse, N.P. Pavletich, Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2–E3 enzyme cascade, Science, 286 (1999) 1321–1326.
• V.P. Ronchi, J.M. Klein, D.J. Edwards, A.L. Haas, The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer, J. Biol. Chem., 289 (2014) 1033–1048.
• V.P. Ronchi, E.D. Kim, C.M. Summa, J.M. Klein, A.L. Haas, In silico modeling of the cryptic E2∼ubiquitin-binding site of E6-associated protein (E6AP)/UBE3A reveals the mechanism of polyubiquitin chain assembly, J. Biol. Chem., 292 (2017) 18006–18023.
• K. Takeda, H. Flechsig, I. Muro, R. Amyot, F. Kobayashi, N. Kodera, T. Ando, H. Konno, Structural Dynamics of E6AP E3 Ligase HECT Domain and Involvement of a Flexible Hinge Loop in the Ubiquitin Chain Synthesis Mechanism, Nano Lett., 23 (2023) 11940–11948.
• D.R. Todaro, A.C. Augustus-Wallace, J.M. Klein, A.L. Haas, Oligomerization of the HECT ubiquitin ligase NEDD4-2/NEDD4L is essential for polyubiquitin chain assembly, J. Biol. Chem., 293 (2018) 18192–18206.
• Z. Hodáková, I. Grishkovskaya, H.L. Brunner, D.L. Bolhuis, K. Belačić, A. Schleiffer, H. Kotisch, N.G. Brown, D. Haselbach, Cryo-EM structure of the chain-elongating E3 ubiquitin ligase UBR5, EMBO J., 42 (2023) e113348.